6078.HK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 23:59):

Stats
Today's Volume	1.82M
Average Volume	2.90M
Market Cap	19.42B
EPS	HKD0 ( 2023-08-29 )
Last Dividend	HKD0.164 ( 2023-06-30 )
Next Dividend	HKD0 ( N/A )
P/E	26.28
ATR14	HKD0.0200 (0.07%)

Volume Correlation

Long: 0.07 (neutral)

Short: -0.87 (strong negative)

Signal:(83.457) Be Aware. Possible trading coming up! (swing)

Hygeia Healthcare Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hygeia Healthcare Correlation - Currency/Commodity

-0.59
( weak negative )

-0.43
( neutral )

0.00
( neutral )

-0.58
( weak negative )

-0.20
( neutral )

0.07
( neutral )

Hygeia Healthcare Financials

Annual	2022
Revenue:	HKD3.20B
Gross Profit:	HKD1.02B (31.83 %)
EPS:	HKD0.770

Q2	2023
Revenue:	HKD1.76B
Gross Profit:	HKD564.56M (32.09 %)
EPS:	HKD0.530

Q4	2022
Revenue:	HKD1.67B
Gross Profit:	HKD523.98M (31.39 %)
EPS:	HKD0.410

Q2	2022
Revenue:	HKD1.53B
Gross Profit:	HKD493.09M (32.31 %)
EPS:	HKD0.360

Financial Reports:

No articles found.

Hygeia Healthcare Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.164 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Hygeia Healthcare Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 9.80 - good (98.04%) | Divividend Growth Potential Score: 3.97 - Decrease likely (20.54%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.144	2021-06-30
Last Dividend	HKD0.164	2023-06-30
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	HKD0.428	--
Avg. Dividend % Per Year	0.00%	--
Score	2.6	--
Div. Sustainability Score	9.80
Div.Growth Potential Score	3.97
Div. Directional Score	6.89	--

Next Divdend (Est)
(2024-11-25)

HKD0.207 Estimate 3.06 %

Dividend Stability

0.24 Very Poor

Dividend Score

2.60

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6818.HK	Ex Dividend Junior	2023-06-26	Annually	0.00%
1930.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
0960.HK	Ex Dividend Knight	2023-12-29	Semi-Annually	0.00%
0088.HK	Ex Dividend Knight	2023-09-01	Semi-Annually	0.00%
3311.HK	Ex Dividend Knight	2023-06-19	Semi-Annually	0.00%
1525.HK	Ex Dividend Knight	2023-06-13	Semi-Annually	0.00%
0576.HK	Ex Dividend Knight	2023-05-08	Annually	0.00%
8473.HK	Ex Dividend Knight	2023-08-15	Annually	0.00%
2096.HK	Ex Dividend Junior	2023-06-19	Annually	0.00%
1110.HK	Ex Dividend Knight	2023-06-01	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.171	1.500	6.58	9.87	[0 - 0.5]
returnOnAssetsTTM	0.0655	1.200	7.82	9.38	[0 - 0.3]
returnOnEquityTTM	0.109	1.500	9.90	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.663	0.800	6.68	5.35	[1 - 3]
quickRatioTTM	1.484	0.800	5.98	4.78	[0.8 - 2.5]
cashRatioTTM	0.945	1.500	5.86	8.79	[0.2 - 2]
debtRatioTTM	0.198	-1.500	6.69	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	1.180	2.00	9.61	10.00	[0 - 30]
freeCashFlowPerShareTTM	-0.215	2.00	-0.108	-0.215	[0 - 20]
debtEquityRatioTTM	0.303	-1.500	8.79	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.317	1.000	8.04	8.04	[0.2 - 0.8]
operatingProfitMarginTTM	0.227	1.000	7.46	7.46	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.419	1.000	8.79	8.79	[0.2 - 2]
assetTurnoverTTM	0.383	0.800	-0.782	-0.626	[0.5 - 2]
Total Score				9.80

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	29.63	1.000	7.11	0	[1 - 100]
returnOnEquityTTM	0.109	2.50	9.94	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.215	2.00	-0.0717	-0.215	[0 - 30]
dividendYielPercentageTTM	0.594	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.180	2.00	9.61	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0691	1.500	-2.87	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.217	1.000	7.07	0	[0.1 - 0.5]
Total Score				3.97

Hygeia Healthcare

Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals that offer oncology healthcare services, such as tumor screening and genetic diagnosis, radiotherapy, surgery, chemotherapy, immunotherapy, targeted therapy, oncology rehabilitation, nutrition, and hospice care. It also provides radiotherapy center consulting services; and licenses its SRT equipment, as well as offers maintenance and technical support services for its SRT equipment. In addition, the company provides hospital and corporate management, and supply chain services. As of December 31, 2021, it operated or managed a network of 12 oncology-focused hospitals in 9 cities in 7 Provinces in the People's Republic of China. Hygeia Healthcare Holdings Co., Limited was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.